Could a sticker on your skin reveal hidden clues about acne and eczema?

NCT ID NCT07549828

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new, non-invasive way to collect and analyze skin oil (sebum) using a simple adhesive patch called Sebutape. Researchers will recruit 200 people, including healthy volunteers and patients with acne, eczema, psoriasis, or seborrheic dermatitis. The goal is to develop a standardized method to measure skin chemicals and microbes, which could eventually help diagnose or monitor skin conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Sebutape sampling and topical antibiotic ointment (Bacitracin/Polymyxin B/Neomycin)

What this could lead to

If successful, this could lead to a simple, non-invasive skin test to help diagnose or monitor skin conditions like acne and eczema.

What could go wrong

This is an early-stage method development study, not a treatment trial. It may not identify useful biomarkers or lead to a practical clinical test.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acne Acne Vulgaris atopic eczema psoriasis seborrheic dermatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••